Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19
Clinical trial NCT04805671 · TERMINATED
Trial details
- NCT number
- NCT04805671
- Sponsor
- Invivyd, Inc.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-26
- Primary completion
- 2022-02-10
- Enrollment
- 399
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.